🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
The goal of the study is to investigate the safety, tolerability and effica...
Status
Recruiting
Location
Save Sight Institute
Start Date
2025-08-29
Trial ID
NCT06628947
Treatments Being Tested
Chronic kidney disease (CKD), is characterized by accelerated development o...
Status
Completed
Location
Poznan University of Medical Sciences
Start Date
2016-03-25
Trial ID
NCT05214872
Treatments Being Tested
This study will evaluate the safety, tolerability, and immunogenicity of va...
Status
Completed
Location
Multiple Locations
Start Date
2013-11-25
Trial ID
NCT01986010
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
Patients suffering from symptomatic carotid artery stenosis, transient isch...
Status
Completed
Location
Site 01: Department of Neurology, TU Munich
Start Date
2013-03-08
Trial ID
NCT01645306
Background: * The National Cancer Institute (NCI) Surgery Branch has devel...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-12-12
Trial ID
NCT01993719
The primary and secondary objectives of this Phase 1 study are respectively...
Status
Completed
Location
Centre for Vaccinology (CEVAC)
Start Date
2020-09-07
Trial ID
NCT04519073
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy such as fludarabine use different way...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2000-01
Trial ID
NCT00006233
RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells...
Status
Completed
Location
Rocky Mountain Cancer Centers - Denver Midtown
Start Date
1999-11
Trial ID
NCT00044954